Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.
This report contains market size and forecasts of Joint Disease Therapeutics in Global, including the following market information:
Global Joint Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Joint Disease Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Joint Disease Therapeutics include AbbVie, Pfizer, Bristol-Myers Squibb, Roche, GlaxoSmithKline, AstraZeneca, Astellas Pharma, Johnson&Johnson and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Joint Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Joint Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Joint Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)
Drug Therapy
Rehabilitation
Surgical Operation
Global Joint Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Joint Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Joint Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Joint Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Joint Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Joint Disease Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Pfizer
Bristol-Myers Squibb
Roche
GlaxoSmithKline
AstraZeneca
Astellas Pharma
Johnson&Johnson
Amgen
Novartis
Sanofi
Daiiachi Sankyo